Balance can be defined as the ability to stand on one leg, regain one's center of gravity after losing it, or walk in a ...

Ambulatory cardiac monitors’ clinical and economic outcomes vary; one long-term continuous monitor brand showed greater arrhythmia diagnosis, fewer retests and cardiovascular events, and lower health ...

Tharimmune, Inc. (Nasdaq:THAR) ("Tharimmune" or the "Company"), a clinical-stage biotechnology company dedicated to developing innovative therapeutic candidates for inflammation, immunology, and ...

Q2 2025 Earnings Call Transcript August 13, 2025 Operator: Ladies and gentlemen, thank you for standing by. Welcome to Absci’s Second Quarter 2025 Business Update Call. [Operator Instructions]. Please ...

Q2 2025 Earnings Call Transcript August 11, 2025 Kymera Therapeutics, Inc. misses on earnings expectations. Reported EPS is $ ...

Phase 1b/2 in MSS CRC shows 19.4-month median OS (mOS) in 10 mg/kg dose cohorts; mOS for 20 mg/kg cohorts has not yet been reached Alignment with FDA on Phase 2 and Phase 3 trial ...

Strengthened balance sheet raising approximately $64 million in gross proceeds in July 2025; cash, cash equivalents, and short-term investments now sufficient to fund operations into the first half of ...

The U.S. has seen a record increase in tariff income, with a 273% rise in customs revenue from last year. However, the budget ...

Taysha Gene Therapies advances pivotal TSHA-102 trial with FDA alignment, strong Q2 performance, and positive clinical data.

Each time we review a website builder we undertake a thorough research and testing process. This is done with the audience in ...

Some people consider it sacrosanct but has World Rugby extended too much latitude to the jackler or ‘stealer’?

MONTREAL and CHARLOTTE, N.C., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST) today reported financial results for the second quarter ended June 30, 2025 and provided ...